Aspira Pathlab Diagnostics Ltd vs Krm Ayurveda Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Aspira Pathlab & Diagnostics Ltd is ₹ 143.34 as of 29 Sep 10:20 . The P/E Ratio of Aspira Pathlab & Diagnostics Ltd is 0 as of March 2024 .The P/E Ratio of KRM Ayurveda Ltd is 0 as of March 2024 . The Market Cap of Aspira Pathlab & Diagnostics Ltd is ₹ 31.91 crore as of March 2024 .The Market Cap of KRM Ayurveda Ltd is ₹ 0 crore as of March 2024 . The revenue of Aspira Pathlab & Diagnostics Ltd for the Jun '25 is ₹ 5.36 crore as compare to the Mar '25 revenue of ₹ 5.91 crore. This represent the decline of -9.31% The revenue of KRM Ayurveda Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Aspira Pathlab & Diagnostics Ltd for the Jun '25 is ₹ 0.79 crore as compare to the Mar '25 ebitda of ₹ 1.05 crore. This represent the decline of -24.76% The ebitda of KRM Ayurveda Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Aspira Pathlab & Diagnostics Ltd changed from ₹ 0.05 crore to ₹ 0.42 crore over 5 quarters. This represents a CAGR of 448.81% The net profit of KRM Ayurveda Ltd changed from ₹ 0 crore to ₹ 0 crore over 5 quarters. This represents a CAGR of 0.0% The Dividend Payout of Aspira Pathlab & Diagnostics Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of KRM Ayurveda Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Aspira Pathlab & Diagnostics Ltd

Aspira Pathlab & Diagnostics Limited (ASDL) was incorporated in July, 1973.
ASDL is a leading pathology specialist, with Pan-India presence.
It offer pathology and diagnostic services to individual patients, hospitals, other healthcare providers, and businesses.
The Company, with a wider presence in Maharashtra India, enjoys a loyal customer base, that reflects on its strength as a brand, providing superior diagnostic testing and services. Presently, Company is engaged into the business of running, owning, managing and administering Diagnostics Centers.
Its principal activities consist of pathology investigation services, radiology investigation services and other related healthcare services at Diagnostic Centres in Mumbai. ASDL ideology is founded on technological supremacy, patient centric approach, and dependable diagnostic results.

About KRM Ayurveda Ltd

KRM Ayurveda Limited was incorporated as a Private Limited Company as 'KRM Ayurveda Private Limited' on September 03, 2019.
Company was converted into a Public Limited Company and the name of Company was changed to 'KRM Ayurveda Limited' on December 24, 2024. Company is operating a network of hospitals and clinics across multiple cities in India as well as marked its presence in abroad through tele medicines consulting and sales.
Presently, Company runs 6 Hospitals and 5 Clinics at different locations in the country.
It integrate authentic Ayurvedic wisdom with modern practices to address chronic, lifestyle, and preventive health needs through personalized care and wellness programs. Though KRM Ayurveda started off as a kidney hospital to provide specialized treatment for kidney disorders, it has widened the horizons in past few years and has now evolved for various health disorders such as kidney disorder, Liver Cirrhosis, Diabetes, Fatty Liver, Arthritis etc.

FAQs for the comparison of Aspira Pathlab & Diagnostics Ltd and KRM Ayurveda Ltd

Which company has a larger market capitalization, Aspira Pathlab & Diagnostics Ltd or KRM Ayurveda Ltd?

Market cap of Aspira Pathlab & Diagnostics Ltd is 129 Cr while Market cap of KRM Ayurveda Ltd is 507 Cr

What are the key factors driving the stock performance of Aspira Pathlab & Diagnostics Ltd and KRM Ayurveda Ltd?

The stock performance of Aspira Pathlab & Diagnostics Ltd and KRM Ayurveda Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aspira Pathlab & Diagnostics Ltd and KRM Ayurveda Ltd?

As of October 25, 2026, the Aspira Pathlab & Diagnostics Ltd stock price is INR ₹126.05. On the other hand, KRM Ayurveda Ltd stock price is INR ₹238.8.

How do dividend payouts of Aspira Pathlab & Diagnostics Ltd and KRM Ayurveda Ltd compare?

To compare the dividend payouts of Aspira Pathlab & Diagnostics Ltd and KRM Ayurveda Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.